Correlation Between Salesforce and Enorama Pharma
Can any of the company-specific risk be diversified away by investing in both Salesforce and Enorama Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Enorama Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Enorama Pharma AB, you can compare the effects of market volatilities on Salesforce and Enorama Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Enorama Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Enorama Pharma.
Diversification Opportunities for Salesforce and Enorama Pharma
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Salesforce and Enorama is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Enorama Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enorama Pharma AB and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Enorama Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enorama Pharma AB has no effect on the direction of Salesforce i.e., Salesforce and Enorama Pharma go up and down completely randomly.
Pair Corralation between Salesforce and Enorama Pharma
Considering the 90-day investment horizon Salesforce is expected to generate 0.28 times more return on investment than Enorama Pharma. However, Salesforce is 3.57 times less risky than Enorama Pharma. It trades about 0.04 of its potential returns per unit of risk. Enorama Pharma AB is currently generating about 0.0 per unit of risk. If you would invest 29,743 in Salesforce on September 1, 2024 and sell it today you would earn a total of 3,256 from holding Salesforce or generate 10.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.47% |
| Values | Daily Returns |
Salesforce vs. Enorama Pharma AB
Performance |
| Timeline |
| Salesforce |
| Enorama Pharma AB |
Salesforce and Enorama Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Enorama Pharma
The main advantage of trading using opposite Salesforce and Enorama Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Enorama Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enorama Pharma will offset losses from the drop in Enorama Pharma's long position.| Salesforce vs. Ke Holdings | Salesforce vs. nCino Inc | Salesforce vs. Kingsoft Cloud Holdings | Salesforce vs. Jfrog |
| Enorama Pharma vs. Kancera AB | Enorama Pharma vs. Cyxone AB | Enorama Pharma vs. Lidds AB | Enorama Pharma vs. Cantargia AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |